Eton Pharmaceutcials
ETON
33 hedge funds and large institutions have $20.9M invested in Eton Pharmaceutcials in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 6 closing their positions.
5,950% more call options, than puts
Call options by funds: $242K | Put options by funds: $4K
100% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 5
0.5% more ownership
Funds ownership: 22.93% → 23.44% (+0.5%)
6% less funds holding
Funds holding: 35 → 33 (-2)
7% less capital invested
Capital invested by funds: $22.5M → $20.9M (-$1.62M)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$368K |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$246K |
| 3 |
AI
Acuitas Investments
Seattle,
Washington
|
+$152K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$86.5K |
| 5 |
Renaissance Technologies
New York
|
+$52.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lido Advisors
Los Angeles,
California
|
-$169K |
| 2 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
-$126K |
| 3 |
VF
Virtu Financial
New York
|
-$67K |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$62.4K |
| 5 |
Jane Street
New York
|
-$61.2K |
ETON Hedge Fund Activity: Q2 2023 in Review
33 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q2 2023, worth a combined $20.9M — down 7.2% from $22.5M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ETON and 4 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 10 added.
The largest buyer was Opaleye Management, adding an estimated $368K. The largest seller was Lido Advisors, exiting entirely with an estimated $169K sold.
- 33 institutional investors held Eton Pharmaceutcials (ETON) as of Q2 2023, down from 35 in Q1 2023.
- Funds reported $20.9M of Eton Pharmaceutcials stock for Q2 2023, down 7.2% quarter-over-quarter.
- 4 funds opened new Eton Pharmaceutcials positions in Q2 2023 and 6 closed out, a net change of -2 holders.
- The largest Eton Pharmaceutcials buyer in Q2 2023 was Opaleye Management, an estimated $368K added.
- The largest Eton Pharmaceutcials seller in Q2 2023 was Lido Advisors, an estimated $169K sold.
Based on aggregated 13F filings for Q2 2023.